Oman vs Tajikistan: Death rate from cancer
Oman
39.97 deaths per 100,000 people
in 2021
Tajikistan
41.32 deaths per 100,000 people
in 2021
Oman rank
178th
Tajikistan rank
175th
Death rate from cancer over time
- Oman
- Tajikistan
How they compare
Tajikistan currently reports 41.32 deaths per 100,000 people against 39.97 deaths per 100,000 people in Oman, a difference of 1.35 deaths per 100,000 people.
Across all 22 years both countries report, Tajikistan has been ahead every year.
Oman ranks 178th and Tajikistan ranks 175th of 194 countries.
Tajikistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Oman | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 48.38 deaths per 100,000 people | 59.74 deaths per 100,000 people | 11.37 deaths per 100,000 people | Tajikistan |
| 2010s | 49.24 deaths per 100,000 people | 53.51 deaths per 100,000 people | 4.27 deaths per 100,000 people | Tajikistan |
| 2020s | 40.87 deaths per 100,000 people | 45.21 deaths per 100,000 people | 4.34 deaths per 100,000 people | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer, Oman or Tajikistan?
- Tajikistan, at 41.32 deaths per 100,000 people against 39.97 deaths per 100,000 people in Oman as of 2021.
- What is the difference in death rate from cancer between Oman and Tajikistan?
- 1.35 deaths per 100,000 people, with Tajikistan ahead.
- How many years of comparable data are there for Oman and Tajikistan?
- 22 years are reported by both, from 2000 to 2021.
- How do Oman and Tajikistan rank globally for death rate from cancer?
- Oman ranks 178th and Tajikistan ranks 175th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes, per 100,000 people.